PHARMICELL revenue breakdown overview

PHARMICELL revenue for the last year amounted to 65.00 B KRW, the most of which — 54.57 B KRW — came from its highest performing source at the moment, Biochemistry Division, the year earlier bringing 58.69 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought PHARMICELL 32.97 B KRW, and the year before that — 34.41 B KRW.